Feature | April 01, 2013

Stress Echo May Be Overused, Leading to False Patient Diagnoses

The American Society of Echocardiography lists five things physicians and patients should question

February 21, 2013 — The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. Fourth in the list, they ask that patients and their doctors talk about the real need for a stress echocardiogram if they do not present conditions that would warn them of a risk of heart disease.

Avoid using stress echocardiograms on asymptomatic patients who meet “low-risk” scoring criteria for coronary disease.

Prior to ordering or undergoing a stress echocardiogram a patient’s risk factors and symptoms should be carefully assessed. The presence of risk factors for heart disease and/or symptoms suggestive of coronary artery disease improves the chance that an abnormal test will reflect true disease in the heart.

Stress testing is performed to determine whether or not there are blockages in the arteries of the heart and whether or not the blockages are severe enough to affect blood flow to the heart. During a stress echocardiogram the heart is challenged either by exposure to exercise or to medications that can simulate the work of exercise. Echo pictures are taken at rest and then following the stress component of the test. Using echo, the presence of a significant blockage causing wall motion abnormalities can be readily identified by evaluating the pumping of the heart muscle. A positive test is a marker of an increased risk of adverse heart events and often leads to further testing such as a cardiac catheterization or aggressive use of medications.

Because of the potential implications of a diagnosis of heart disease, it is important to make sure that the results of the test are accurate. Performing the test in individuals who have some risk for heart disease increases the chances that a positive represents true disease. Risk factors for coronary artery disease, using the scoring mechanism common in patient heart evaluations, include cigarette smoking, high blood pressure, high cholesterol, positive family history of heart artery disease, obesity, inactivity, diabetes mellitus and peripheral vascular disease. Having one or more of these factors increases the likelihood that chest pain actually represents underlying heart artery disease. Symptoms suggestive of heart artery disease include pressure/pain in the mid-chest that occurs with exertion. The discomfort can also spread to the arms, back, neck or jaw, and can be associated with shortness of breath.

Individuals without these symptoms or risk factors for heart disease are less likely to have heart artery blockages and should not undergo surveillance stress echocardiography or any other stress test due to the risk of obtaining a falsely positive test.

The goal of Choosing Wisely is to promote conversations between physicians and patients about utilizing the most appropriate tests and treatments and avoiding care that may provide no benefit.

ASE’s testing cardiovascular care scenarios were chosen based on the highest likelihood of improving patient care and reducing inappropriate test use. Leaders in the organization transformed the scenarios into plain language and produced the clinical explanations for each procedure. In particular, ASE’s cardiovascular care experts, reviewed the ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriateness UseCriteria for Echocardiography (AUC), which was published in March 2011.

ASE encourages all medical professionals engaged in cardiovascular care to read the “Five Things Physicians and Patients Should Question” and to engage patients in conversations about reducing inappropriate tests and procedures with a goal of improving care and avoiding harm.

Consumer Reports, along with a coalition of consumer partner organizations, is also a part of the Choosing Wisely effort and is working with many of the societies to help patients understand the tests and treatments that are right for them.

For more information: www.asecho.org, www.choosingwisely.org

Related Content

Philips, TCT 2016, image guidance technologies, iFR, HeartNavigator
News | Cath Lab| October 26, 2016
Philips recently announced its latest image guidance solutions to be featured at the 2016 Transcatheter Cardiovascular...
pediatric echocardiograms, cardiovascular ultrasound, therapy dog impact, animal-assisted therapy, Human Animal Bond Research Initiative, HABRI
News | Cardiovascular Ultrasound| October 25, 2016
The Human Animal Bond Research Initiative (HABRI) announced it has awarded a $44,000 grant to Duke University School of...
Analogic Corp., bk3500 ultrasound system, cardiac imaging software, ACEP 2016, RSNA 2016
News | Cardiovascular Ultrasound| October 18, 2016
Analogic Corp. announced last week that it will introduce its new premium cardiac imaging software for the bk3500...
Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
GE Healthcare, Optison ultrasound contrast agent, FDA labeling change, cardiac shunts, intra-arterial injection
Technology | Contrast Media| October 04, 2016
GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change for the ultrasound...
Sci-image, Scimage, CVIS, CIIMS, Cpacs c-pacs, cardiovascular information system

Today's cardiovascular information systems need to incorporate all facets of the cardiology department, including subspecialties, to allow a complete picture of a patient's record. These data also need to be able to be shared with enterprise data systems, such as the electronic medical record (EMR). This image is from ScImage, illustrating the various aspects that integrate to make up a complete CVIS. 

 

Feature | September 29, 2016 | Val Kapitula, RT(R), PMP, CIIP
 
GE Healthcare, Vivid iq portable cardiovascular ultrasound, RSNA 2016, launch
Technology | Cardiovascular Ultrasound| September 22, 2016
September 22, 2016 — GE Healthcare announced the global commercial launch of its new generation of high-end portable
Transesophageal Echo, TEE. Interventional echocardiography, interventional echo, Philips, CX50

Transesophageal echo (TEE) has become an essential part of the new transcatheter structrual heart therapies, giving rise to a new sub-speciality of interventional echocardiography.  

Feature | Cath Lab Navigation Aids| September 21, 2016 | Dave Fornell
The rapid growth of transcatheter structural heart procedures and the need for increased use of echocardiography as a
Toshiba, Aplio 500 Platinum ultrasound, International Contrast Ultrasound Society, ICUS, live case, contrast-enhanced ultrasound
News | Ultrasound Imaging| September 07, 2016
September 7, 2016 — Toshiba America Medical Systems Inc.
best ultrasound technician schools, 2016 ranking, College Choice
News | Ultrasound Imaging| August 22, 2016
August 22, 2016 — College Choice, a leading authority in college and university rankings and resources, has published
Overlay Init